Cargando…
Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma
It is increasingly recognized that chimeric RNAs may exert a novel layer of cellular complexity that contributes to oncogenesis and cancer progression, and could be utilized as molecular biomarkers and therapeutic targets. To date yet no fusion chimeric RNAs have been identified in esophageal cancer...
Autores principales: | Zhang, Hao, Lin, Wan, Kannan, Kalpana, Luo, Liming, Li, Jing, Chao, Pei-Wen, Wang, Yan, Chen, Yu-Ping, Gu, Jiang, Yen, Laising |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875775/ https://www.ncbi.nlm.nih.gov/pubmed/24243830 |
Ejemplares similares
-
Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma
por: Kannan, Kalpana, et al.
Publicado: (2015) -
Chimeric RNA Design Principles for RNA-Mediated Gene Fusion
por: Gupta, Sachin Kumar, et al.
Publicado: (2022) -
Coordinated Regulation of Protoperithecium Development by MAP Kinases MAK-1 and MAK-2 in Neurospora crassa
por: Lan, Nan, et al.
Publicado: (2021) -
CDKN2D-WDFY2 Is a Cancer-Specific Fusion Gene Recurrent in High-Grade Serous Ovarian Carcinoma
por: Kannan, Kalpana, et al.
Publicado: (2014) -
Recent advances of GOLM1 in hepatocellular carcinoma
por: Yan, Jiuliang, et al.
Publicado: (2020)